The definitive exact-match pair: MedicalCordBlood.com + CordBlood.us. Comps: CordBlood.com $250K+, StemCell.com $200K+. Contact us for exclusive bundle pricing!
The cord blood banking market is $4.2B in 2025, projected to reach $7-9B by 2030 (12-15% CAGR). These 2 exact-match domains provide complete category coverage—medical professionals use "medical cord blood" while U.S. families search "cord blood."
Estimated Value: $35,000 - $60,000
THE category-defining domain for cord blood banking. "Medical cord blood" is the professional, authoritative term used by OB/GYNs, hospitals, and medical literature. Perfect for private cord blood banks, public cord blood registries, medical information portals, or hospital cord blood donation programs. Positions as medical-grade, clinical service.
Use Cases
Private cord blood bank (Cryo-Cell model), public cord blood registry, hospital donation program portal, medical education platform, stem cell research institute
Natural Buyers
Cryo-Cell ($100M+ revenue), ViaCord (acquired by PerkinElmer), CBR (Cord Blood Registry), FamilyCord, Americord, Lifebank, Maze Cord Blood
Revenue Model
Private banking: $1,500-2,500 enrollment + $150-300/year storage = $150M+ potential revenue with 50K clients. Affiliate: Refer clients to cord blood banks for $200-500 per enrollment. B2B: License domain to hospital networks for donation programs.
Estimated Value: $15,000 - $30,000
"Cord blood" is THE consumer term. Parents Google "cord blood banking" before delivery. CordBlood.us captures U.S. market specifically—crucial since cord blood banking regulations vary by country. Perfect for U.S.-focused cord blood bank, comparison site, or educational portal targeting American families.
Why .us Extension Works: Cord blood regulations are country-specific. U.S. families want U.S.-based banks (FDA oversight, domestic storage). CordBlood.us signals "U.S. market authority" better than generic .net or .org alternatives.
Comparable Sales: CordBlood.com sold for $250K+. CordBlood.us at $15K-30K is a bargain by comparison—same brand, different TLD, 90% discount.
Medical Breakthrough: Cord blood stem cells treat 80+ diseases (leukemia, lymphoma, sickle cell, cerebral palsy). FDA-approved treatments = credibility.
Insurance Coverage Expanding: Some states mandate insurance cover cord blood for high-risk pregnancies. Medicaid reimbursement in select cases.
Celebrity Endorsement: Kim Kardashian, Serena Williams publicly stored cord blood. Mainstream = mass adoption.
Public + Private Model: Can donate to public registry (free) OR bank privately ($2K). Both need marketing = domain demand.
Major Private Banks: Cryo-Cell ($100M+ revenue), CBR (acquired by AMAG for $700M), ViaCord (PerkinElmer subsidiary), FamilyCord, Americord (Series B $30M funding).
Public Registries: National Marrow Donor Program, Be The Match, state-funded cord blood banks need public awareness domains.
Hospital Networks: Kaiser, HCA Healthcare, Mayo Clinic offer cord blood donation—need consumer-facing portals.
International Expansion: Asian cord blood banks (China Cord Blood Corp $2B valuation) entering U.S. market need authoritative domains.
You own BOTH angles: MedicalCordBlood.com = professional/clinical authority (doctors, hospitals, research). CordBlood.us = consumer-facing U.S. market leader (expectant parents, comparison shoppers). Competitors can't outrank you on either front. Complete category lockout.
Comparable Domain Sales: CordBlood.com sold for $250K+. StemCell.com sold for $200K+. Cells.com sold for $275K. You're getting MedicalCordBlood.com (more descriptive, medically authoritative) + CordBlood.us for $49,999—a fraction of those comps.
Why Now: CBR sold for $700M to AMAG Pharmaceuticals. Americord raised $30M Series B. Cryo-Cell trades publicly ($100M+ market cap). Major acquisitions = strategic buyers actively seeking domains to expand market share. These domains never come available again.